No Controversy Here

While controversy exists in the USA concerning research with embryonic stem cells, everyone agrees that using adult stem cells are appropriate and efficacious. Rabin Medical Center has made a major breakthrough in applying adult stem cells to treat Parkinson's disease by developing NurOwn, a technology that generates neuron-like cells derived from human bone marrow. Using the patient's own bone marrow to supply dopamineproducing cells circumvents problems of immunity and compatibility. Credit for the discovery goes to Prof. Eldad Melamed, Director of Neurology at the Rabin Medical Center and member of the Michael J. Fox Foundation for Parkinson's Research, together with Dr. Daniel Offen, Director of Laboratory of Neurosciences at Rabin Medical Center, and Dr. Yosef Levy. Commercialized by Brainstorm Cell Therapeutics based in Tel Aviv, NurOwn actually produces the missing chemical that enables restoration of motor movement.

Related Articles

Laron's Syndrome A Rare Genetic Syndrome Causing Dwarfism: Professor Laron Receives The 2009 Israel Prize For Medical Research


Professor Zvi Laron has been awarded The 2009 Israel Prize for Medical Research, the country's highest honor, for his groundbreaking research on growth hormone activity.


read more »

Kidney Transplant Breakthrough Saves Lives


Kidneys are the most commonly transplanted organs in the US and in Israel, but there is still a huge shortage of available organs.


read more »

Robotic Gynecological Surgery


The American Friends of Rabin Medical Center welcomed the New England Chapter on May 6, 2012 to a private brunch hosted by long time supporters of Rabin Medical Center.


read more »